5Sigmundsdottir H Johnsfon A,Gudjonsson JE,etal.NarrowbanduvB irradiation Tcells.Arch Dermatol Res,2004,295:509-516.
6Abraham S,Lehmann B,Knuschke P,etal.UVB-induced conversion of T-dehydro cholesterol to lalpa,25-dihydsoxyvitamin D(calcitriol) in cul-tured Keratinocytes in upregulated by tumor necrosis factor alpha[J].Exp Dermatol,2005,14:154.
7Piski G,Tursen u,Sylva-stfeenland RM,etal clinical improvement in chronic plague-type psoriasis esions after narrow-land UVB therapy is a wompanied by a decrease in the expression of IFNgamma inducers-IL-12,IL-18 and IL-23[J].Exp Dermtol,2004,13:764-772.
二级参考文献24
1Gottlieb A, Krueger JG, Bright R, et al. Effects of administration of a single dose of humanized monoclonal antibody to CDlla on the immunobiology and clinical activity of psoriasis. J Am Acad Dermatol 2000; 42: 428-435.
2Gottlieb A, Miller B, Chaudhari U, et al.Clinical and histologic effect of subcutaneously administered anti - CDlla in patients with psoriasis. J Invest Dermatol 2000;114:840.
3Gottlieb A, Abdulghani A, Totoritis R, et al.Results of a single- dose, dose - escalating trial of anti- B7 monoclonal antibody (IDEC-114) in patients with psoriasis. J Invest Dennatol 2000; 114:546.
4Ravindra A, Nitika V. Biotherapy: a novel approach in the treatment of psoriasis. Drugs of the Fut:Lre 2002;27:1071 - 1077.
5Krueger JG, Waiters B, Miyazawa M, et al.Successful in vivo blockade of CD25 on T cells by administration of humanized anti - Tac antibody to patients with psoriasis. J Am Acad Dermatol 2000;43:448-458.
6Asadullah K, Friedrich M, Hanneken S, et al. Effects of systemic interleukin - 10 therapy on psoriatic skin lision: histologic, immunohistologic and molecular biology findings. J Invest Dermatol 2001 ; 116:721 - 727.
7Duan H, Koga T, Kohda F, et al. Interleukin- 8 positive neutrophils in psoriasis. J Deamatol Sci 2001;26:119.
8Lohner ME, Krueger JG, Gottlieb A, et al.Clinical trals of a fully human anti - IL - 8 antibody for the treatment of psoriasis. Br J Dermatol 1999; 141:989.
9Oh CJ, Das KM, Gottlieb AB. Treatment with anti - tumor necrosis factor ( TNF - α)monoclonal antibody dramatically decreases the clinical activity of psoriasis lesions. J Am Aead Dermatol 2000;42:829 - 830.
10Kirby B, Marsland AM, Carnichael A J, et al. Successful treatment of severe recalcitrant psoriasis with combination infliximab and methotrexata. Clin Exp Dermatol 2001;26:27-29.
3ferenczi K, Burack L, Pope M, et al. CD69. HLA-DR and the IL-2Ridengtify peristentenly activated T cells in psoriasis vulgaris lesionalskin: blood and skin comparisons by flow cytometry[J]. JAutoimmun, 2000, 14(1): 63-78.
4Kimura A, Kishimoto T. IL-6: regulator of Treg/Th17 balance[J]. EurJ Immunol, 2013, 40(9): 1830-1835.
5Quaglino P, Bergallo M, Ponti R, et al. Th1, Th2, Th17 andRegulatory T Cell Pattern in Psoriatic Patients: Modulation ofCytokines and Gene Targets Induced by Etanercept Treatment andCorrelation with Clinical Response[J]. Dermatology, 2011, 223(1):57-67.
6Kagami S, Rizzo HL, Lee JJ, et al. Circulating Th17, Th22, and Th1cells are increased in psoriasis[J]. J Invest Dermatol, 2010, 130(5):1373-1383.
7Sledziska A, Hemmers S, Mair F, et al. TGF-β signalling is requiredfor CD4、T cell homeostasis but dispensable for regulatory T cellfunction[J]. Plos Biology, 2013, 11(10): e1001674.
8Ozawa M, Ferenczi K, Kikuchi T, et al. 312-nanometer ultraviolet Blight (narrow-band UVB) induces apoptosis of T cells withinpsoriatic lesions[J]. J Exp Med, 1999, 189(4): 711-718.
9Szepietowski JC, Morita A, Tsuji T. Ultraviolet B induces mast cellapoptosis: a hypothetical mechanismof ultraviolet B treatment foruraemic pruritus[J]. Med Hypotheses, 2002, 58(2): 167-170.
